BioSpace News Archive

The Preeclampsia Foundation announced today the recipients of its 2022 Peter Joseph Pappas Research Grants at the Society for Maternal Fetal Medicine 42nd Annual Pregnancy Meeting.

February 3, 2022, collaboration agreement was signed between Allosteric Bioscience, a company founded in 2021 integrating Quantum Computing and Artificial Intelligence with Biomedical sciences to create improved treatments for Aging and Longevity and Polaris Quantum Biotech, a company at the vanguard of Quantum Computing for drug discovery.

Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric platforms, today announced the close of a $26 million Series B financing.

EuBiologics (KOSDAQ: 206650, CEO, Dr. Baik YoungOk, Mr. Seukkeun Choi), a South Korean biotech company, announced on Jan 28th that EuCorVac-19, a COVID-19 vaccine candidate developed by EuBiologics, obtained approval to conduct Phase III comparison clinical trials (Phase III IND Approval) from the Ministry of Food and Drug Safety in South Korea.

Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its fourth quarter and full year 2021 financial results on Thursday, February 17, 2022.

Dr. McGlennen brings unique and valuable expertise to TELO’s board with extensive experience in successfully introducing novel diagnostics technologies into clinical laboratories across the USA.

Incorporation of AI into radiology is revolutionizing this field of medical imaging with machine intelligence and deep learning algorithms.

According to Emergen Research, the global depression treatment market size was USD 12.06 billion in 2019 and is expected to reach USD 16.06 billion in 2027 and register a revenue CAGR of 3.9% during the forecast period, 2020-2027.

Pharmaceutical Associates, Inc. (PAI) announces that it has acquired all of the generic and branded US marketing authorizations from Teligent Inc. (Teligent) for an undisclosed amount.

American Regent announces the introduction and availability of FDA-approved Vasopressin Injection, USP.